|
1
|
Morgan RJ Jr, Alvarez RD, Armstrong DK,
Boston B, Burger RA, Chen LM, Copeland L, Crispens MA, Gershenson
D, Gray HJ, et al: National Comprehensive Cancer Network:
Epithelial ovarian cancer. J Natl Compr Canc Netw. 9:82–113.
2011.PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Colombo N, Peiretti M, Parma G, et al:
Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO
Clinical Practice Guidelines for diagnosis, treatment and
follow-up. Ann Oncol. 21:v23–v30. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Baron V, Calléja V, Ferrari P, Alengrin F
and Van Obberghen E: p125Fak focal adhesion kinase is a substrate
for the insulin and insulin-like growth factor-I tyrosine kinase
receptors. J Biol Chem. 273:7162–7168. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
McLean GW, Carragher NO, Avizienyte E,
Evans J, Brunton VG and Frame MC: The role of focal-adhesion kinase
in cancer - a new therapeutic opportunity. Nat Rev Cancer.
5:505–515. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nikitenko LL, Leek R, Henderson S, et al:
The G-protein-coupled receptor CLR is upregulated in an autocrine
loop with adrenomedullin in clear cell renal cell carcinoma and
associated with poor prognosis. Clin Cancer Res. 19:5740–5748.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Halder J, Landen CN, Lutgendorf SK, et al:
Focal adhesion kinase silencing augments docetaxel-mediated
apoptosis in ovarian cancer cells. Clin Cancer Res. 11:8829–8836.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang YT, Lee LT, Lee PP, Lin YS and Lee
MT: Targeting of focal adhesion kinase by flavonoids and
small-interfering RNAs reduces tumor cell migration ability.
Anticancer Res. 25:2017–2025. 2005.PubMed/NCBI
|
|
9
|
Gao M, Liu X, Sun H, Ren H, Wang L and
Shen Y: Study on FAK regulation of migration of vascular
endothelial cells depending upon focal adhesion proteins. Sheng Wu
Yi Xue Gong Cheng Xue Za Zhi. 30:567–571. 2013.(In Chinese).
PubMed/NCBI
|
|
10
|
Grisaru-Granovsky S, Salah Z, Maoz M,
Pruss D, Beller U and Bar-Shavit R: Differential expression of
protease activated receptor 1 (Par1) and pY397FAK in benign and
malignant human ovarian tissue samples. Int J Cancer. 113:372–378.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Saldanha SN and Tollefsbol TO: Pathway
modulations and epigenetic alterations in ovarian tumorbiogenesis.
J Cell Physiol. 229:393–406. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sood AK, Coffin JE, Schneider GB, Fletcher
MS, DeYoung BR, Gruman LM, Gershenson DM, Schaller MD and Hendrix
MJ: Biological significance of focal adhesion kinase in ovarian
cancer: role in migration and invasion. Am J Pathol. 165:1087–1095.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Judson PL, He X, Cance WG and Van Le L:
Overexpression of focal adhesion kinase, a protein tyrosine kinase,
in ovarian carcinoma. Cancer. 15:1551–1556. 1999. View Article : Google Scholar
|
|
14
|
Frede S, Freitag P, Otto T, Heilmaier C
and Fandrey J: The proinflammatory cytokine interleukin 1beta and
hypoxia cooperatively induce the expression of adrenomedullin in
ovarian carcinoma cells through hypoxia inducible factor 1
activation. Cancer Res. 65:4690–4697. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cuttitta F, Pío R, Garayoa M, Zudaire E,
Julián M, Elsasser TH, Montuenga LM and Martínez A: Adrenomedullin
functions as an important tumor survival factor in human
carcinogenesis. Microsc Res Tech. 57:110–119. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zudaire E, Martinez A and Cuttitta F:
Adrenomedullin and cancer. Regul Pept. 112:175–183. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pang X, Shang H, Deng B, Wen F and Zhang
Y: The Interaction of Adrenomedullin and Macrophages Induces
Ovarian Cancer Cell Migration via Activation of RhoA Signaling
Pathway. Int J Mol Sci. 14:2774–2787. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Provenzano PP and Keely PJ: The role of
focal adhesion kinase in tumor initiation and progression. Cell Adh
Migr. 3:347–350. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Karpinich NO, Hoopes SL, Kechele DO,
Lenhart PM and Caron KM: Adrenomedullin function in vascular
endothelial cells: Insights from genetic mouse models. Curr
Hypertens Rev. 7:228–239. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zudaire E, Martínez A, Garayoa M, Pío R,
Kaur G, Woolhiser MR, Metcalfe DD, Hook WA, Siraganian RP, Guise
TA, et al: Adrenomedullin is a cross-talk molecule that regulates
tumor and mast cell function during human carcinogenesis. Am J
Pathol. 168:280–291. 2006. View Article : Google Scholar : PubMed/NCBI
|
